• 제목/요약/키워드: Mood disorder

검색결과 385건 처리시간 0.029초

뇌졸중 후 정서장애에 대한 임상보고 (A Clinical Studies on the Poststroke Mood Disorder)

  • 유경숙;손동혁;장인수;이진구;윤희식;서웅;이영구
    • 대한한방내과학회지
    • /
    • 제21권4호
    • /
    • pp.641-647
    • /
    • 2000
  • Objective : The purpose of this study was to examine the mood disorder, especially depression and anxiety which have an effect on rehabilitation in stroke patients. Methods : Subjects were 32 stroke patients who were inpatients and outpatients at Woosuk University oriental hospital. The degree of depression and anxiety was measured by the Beck Depression Inventory(BDI) and State-Trait Anxiety Inventory(STAI, State Anxiety Inventory : SAI, Trait Anxiety Inventory: TAI). Other questionnaire included sex, age, onset of stroke, degree of education, econommic class, religion, relationship with family, expectancy on treatment, side of hemiplegia, weakness grade of hemiplegia. Results : Results were as follows. 1. The average scores of SAI, TAI and BDI were 45.7, 46.7 and 19.9. The percentages of patients who had relatively high SAI, TAI and BDI scores were 75%(>36 point), 87.5%(>36 point) and 56.2%(>16 point). 2. SAI was correlated with onset of stroke(p<0.05), religion and relationship with family(p<0.1 ), TAI with religion and BDI with weakness grade of hemiplegia(P

  • PDF

Venlafaxine 투여로 회복을 보인 공황장애와 범불안장애가 병발한 환자의 치료 1예 (The Effect of Venlafaxine in One Patient with Panic Disorder and Generalized Anxiety Disorder : A Case Report)

  • 최홍;윤세창
    • 대한불안의학회지
    • /
    • 제2권1호
    • /
    • pp.56-60
    • /
    • 2006
  • Panic disorder is a relatively common psychiatric illness (life time prevalence 3.5%), and it is known that 91% of patients with panic disorder have at least one other psychiatric disorder. And patients with panic disorder, who have coexisting generalized anxiety disorder, tend to have more severe symptoms and less favorable outcome and respond less well to psychological and pharmacologic treatment. The authors report a 51-year old male who was previously diagnosed as panic disorder in the out-patient clinic, showed poor response to antipanic treatment. However, he showed great improvement after he was treated for panic disorder and comorbid generalized anxiety disorder. This case report showed that more effort to identify comorbid conditions is needed in panic disorder patients and the effectiveness of venlafaxine in the treatment of panic disorder with generalized anxiety disorder.

  • PDF

사회불안장애의 인지행동치료 (Cognitive-Behavioral Therapy for Social Anxiety Disorder)

  • 이재헌
    • 대한불안의학회지
    • /
    • 제12권1호
    • /
    • pp.42-46
    • /
    • 2016
  • The therapeutic effect of cognitive behavioral therapy (CBT) for patients with Social Anxiety Disorder (SAD) is supported by evidence from numerous studies. This article provides an overview of cognitive models and major techniques (i.e., cognitive restructuring and exposure) of CBT for SAD, developed by the study group of SAD in the Korean Academy of Anxiety Disorder. Korean-culture specific factors and new trends such as a third wave of CBT are also described.

  • PDF

기분장애 환자에서 한의치료 이용과 관련된 요인분석: 제2기 한국의료패널 자료를 중심으로 (Analysis of Factors Related to the Use of Korean Medicine Treatment in Patients with Mood Disorders: Based on 2019 Korea Health Panel Annual Data)

  • 이경은;권찬영
    • 동의신경정신과학회지
    • /
    • 제34권4호
    • /
    • pp.349-358
    • /
    • 2023
  • Objectives: We used the 2019 Korea Health Panel Annual Data to analyze factors related to visits to Korean medicine (KM) outpatient clinics among patients with mood disorders in Korea. Methods: Individuals aged 19 years or older, with depressive or bipolar disorders, and with a record of using Western medicine (WM) and/or the KM medical service were included. The 266 subjects were classified into the WM group or the integrative medicine (IM) group. The Andersen healthcare utilization model was used to analyze factors that potentially influenced the subjects' healthcare utilization. Binomial logistic regression analysis was used to analyze factors influencing the use of IM medical services. Results: Among the subjects, 75.56% (n=201) were in the WM group, and 24.44% (n=65) were in the IM group. Statistically significant differences were observed in residential areas, total annual income, the presence of disability, and the level of pain/discomfort between the two groups. Regression analysis found that residential areas and pain/discomfort were factors related to the use of IM services. Specifically, reporting "a lot" of pain/discomfort compared to "no" pain/discomfort showed a significant positive relationship with the use of IM (odds ratio=4.57, 95% confidence interval=1.79 to 11.70). Conclusions: This study was the first to analyze the status of KM medical service use and related factors among patients with mood disorders in Korea. The finding that the presence of pain/discomfort was positively correlated with the use of KM services is potentially related to medically unexplained physical symptoms or somatization phenomena.

기분장애의 병리와 치료에 있어 세로토닌의 역할 (The Role of Serotonin in Pathology and Treatment of the Mood Disorders)

  • 정인과;김진세
    • 생물정신의학
    • /
    • 제4권2호
    • /
    • pp.168-178
    • /
    • 1997
  • The serotonin has been known to play important roles in pathology of the mood disorders. We summerize the evidences of serotonin in pathology of the mood disroders in a view of neuroanatomical and neurochemical aspects. Nowaday, the selective serotonin reuptake inhibitors(SSRIs) may be practically the first line of antidepressants with traditional tricyclic antidepressants(TCAs). Authors review the role of serotonin in the treatment of the mood disorders, in a view of the general considerations in selecting antidepressants, pharmacology, therapeutic indications, side effects, doses of medication, drug-discontinuation syndrome, drug-to-drug interactions, and special therapeutic situations.

  • PDF

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review

  • Shim, In Hee;Bahk, Won-Myong;Woo, Young Sup;Yoon, Bo-Hyun
    • Clinical Psychopharmacology and Neuroscience
    • /
    • 제16권4호
    • /
    • pp.376-382
    • /
    • 2018
  • We reviewed clinical studies investigating the pharmacological treatment of major depressive episodes (MDEs) with mixed features diagnosed according to the dimensional criteria (more than two or three [hypo]manic symptoms+principle depressive symptoms). We systematically reviewed published randomized controlled trials on the pharmacological treatment of MDEs with mixed features associated with mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD). We searched the PubMed, Cochrane Library, and ClinicalTrials.gov databases through December 2017 with the following key word combinations linked with the word OR: (a) mixed or mixed state, mixed features, DMX, mixed depression; (b) depressive, major depressive, MDE, MDD, bipolar, bipolar depression; and (c) antidepressant, antipsychotic, mood stabilizer, anticonvulsant, treatment, medication, algorithm, guideline, pharmacological. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We found few randomized trials on pharmacological treatments for MDEs with mixed features. Of the 36 articles assessed for eligibility, 11 investigated MDEs with mixed features in mood disorders: six assessed the efficacy of antipsychotic drugs (lurasidone and ziprasidone) in the acute phase of MDD with mixed features, although four of these were post hoc analyses based on large randomized controlled trials. Four studies compared antipsychotic drugs (olanzapine, lurasidone, and ziprasidone) with placebo, and one study assessed the efficacy of combination therapy (olanzapine+fluoxetine) in the acute phase of BD with mixed features. Pharmacological treatments for MDEs with mixed features have focused on antipsychotics, although evidence of their efficacy is lacking. Additional well-designed clinical trials are needed.

자살시도로 응급실에 내원한 환자의 자살 위험성과 양극성 장애 가능성의 연관성 (The Relationship between Possibility of Bipolar Disorder and Suicidal Attempt in Emergency Room)

  • 허량;김건형;전진호;박영민;김영훈;이봉주
    • 정신신체의학
    • /
    • 제23권2호
    • /
    • pp.107-113
    • /
    • 2015
  • 연구목적 본 연구는 자살 시도자를 대상으로 자살 생각의 심각성과 관련된 요인들을 찾아보고자 하였다. 방 법 일 대학병원 응급실에 자살 시도로 내원한 환자 중 50명을 대상으로 임상가가 면담, Columbia Suicide Severity Rating Scale(C-SSRS), Beck Depression Inventory(BDI), Korean Version of Mood Disorder Questionnaire(K-MDQ), Bipolar Spectrum Diagnostic Scale(BSDS)를 시행하였다. 결 과 자살 경향이 높은 고위험군은 C-SSRS의 자살 생각의 심각성 점수와 BDI 점수가 높았고(p<0.001), MDQ에서 양극성 장애 가능성의 양성으로 판정된 자는 자살생각의 심각성 점수가 높았다(p=0.033). 결 론 자살 시도자의 자살 생각의 심각성과 양극성 장애의 가능성은 서로 연관성이 있을 것으로 생각된다.

정서장애 환자의 월경전기변화 특성 (Characteristics of Premenstrual Changes in Patients with Affective Disorder)

  • 고영훈;조숙행;서광윤
    • 정신신체의학
    • /
    • 제7권1호
    • /
    • pp.103-115
    • /
    • 1999
  • 연구목적 : 월경전기증후군에서 나타나는 증상 양상, 가족력, 높은 정서장애의 유병율은 이 질환의 정서장애와의 관련성을 시사해 주며 한편, 월경주기에 따른 정서장애 임상경과의 변화도 제시되고 있다. 본 연구는 정신과 외래 통원 치료를 받고 있는 정서장애 환자군과 대조군을 대상으로 하여 월경전기변화의 양상과 정도를 비교하고 일상 및 직업 생활에의 영향 및 환자군에서의 월경전기변화에 대한 가능성 있는 위험 요인들을 알아보고자 하였다. 방법 : 본 연구는 정신과 외래 통원 치료를 받고 있는 여성 정서장애 환자 80명과 정상 대조군 80명을 대상으로 하였다. 월경전기변화는 DSM-IV 월경전기불쾌기분장애의 진단기준 A를 세분화한 4점 척도의 16항목으로 구성된 자기 평가 형식의 설문지를 통해 후향적인 방법으로 평가되었다. 결과 : 1) 월경전기변화의 항목 중 한가지 이상에서 중등도 이상의 변화를 경험하는 월경전기변화군이 정서 장애 환자군은 32.6%. 대조군은 50%로 환자군에서 대상이 적었다. 2) 월경전기변화군에서 대조군은 기분 또는 행동 변화와 신체적인 변화를 호소하는 경우가 비슷한 분포로 나타났으나, 환자군은 기분 또는 행동 변화만을 호소하는 경우가 유의하게 많았다. 월경전기변화군에서 대조군은 신체적인 변화인 유방 통증의 빈도가 가장 높았던 반면 환자군에서는 기분이나 행동 변화인 피로감과 무기력의 빈도가 가장 높았다. 3) 대조군은 기분이나 행동 변화와 신체적인 변화가 많을수록 일상이나 사회 생활에 심한 장애를 경험하는 반면 환자군에서는 기분 또는 행동 변화만이 빈도가 높을수록 심한 일상이나 사회 생활의 장애를 경험하였다. 4) 환자군에서 월경전기변화군은 월경전기변화가 없는 군에 비해 월경통을 보고하는 경우가 유의하게 많았으며, 그 심각도는 월경전기변화의 빈도와 상관 관계를 나타내었다. 결론 : 정서 장애 환자군의 월경전기변화는 신체적 변화보다 기분 행동 변화가 두드러지는 특성을 보였다. 이들 환자군의 월경전기변화는 기존 질환의 월경전기악화 또는 기존 질환과 동반되는 월경전기증후군의 가능성을 제시해 준다. 또한, 환자군에서는 월경전기변화 특히 기분 또는 행동 변화의 빈도가 높을수록 심한 일상 생활의 장애를 경험하였다. 따라서, 정서장애 환자에서의 월경전기변화에 대한 정확한 평가와 이에 대한 적절한 치료 전략의 수립이 필요하리라 본다.

  • PDF

Implications of Circadian Rhythm in Dopamine and Mood Regulation

  • Kim, Jeongah;Jang, Sangwon;Choe, Han Kyoung;Chung, Sooyoung;Son, Gi Hoon;Kim, Kyungjin
    • Molecules and Cells
    • /
    • 제40권7호
    • /
    • pp.450-456
    • /
    • 2017
  • Mammalian physiology and behavior are regulated by an internal time-keeping system, referred to as circadian rhythm. The circadian timing system has a hierarchical organization composed of the master clock in the suprachiasmatic nucleus (SCN) and local clocks in extra-SCN brain regions and peripheral organs. The circadian clock molecular mechanism involves a network of transcription-translation feedback loops. In addition to the clinical association between circadian rhythm disruption and mood disorders, recent studies have suggested a molecular link between mood regulation and circadian rhythm. Specifically, genetic deletion of the circadian nuclear receptor Rev-$erb{\alpha}$ induces mania-like behavior caused by increased midbrain dopaminergic (DAergic) tone at dusk. The association between circadian rhythm and emotion-related behaviors can be applied to pathological conditions, including neurodegenerative diseases. In Parkinson's disease (PD), DAergic neurons in the substantia nigra pars compacta progressively degenerate leading to motor dysfunction. Patients with PD also exhibit non-motor symptoms, including sleep disorder and neuropsychiatric disorders. Thus, it is important to understand the mechanisms that link the molecular circadian clock and brain machinery in the regulation of emotional behaviors and related midbrain DAergic neuronal circuits in healthy and pathological states. This review summarizes the current literature regarding the association between circadian rhythm and mood regulation from a chronobiological perspective, and may provide insight into therapeutic approaches to target psychiatric symptoms in neurodegenerative diseases involving circadian rhythm dysfunction.

양극성장애에서의 공존 불안 (Comorbid Anxiety in Bipolar Disorder)

  • 김경원;문은수
    • 대한불안의학회지
    • /
    • 제20권1호
    • /
    • pp.1-7
    • /
    • 2024
  • This review article summarizes the main research findings on the presence of anxiety disorders in individuals with bipolar disorder. It examines the prevalence of comorbid anxiety disorders in bipolar disorder, which is generally high. Moreover, it explores the variations in comorbid anxiety across different subtypes of bipolar disorder. The article also investigates the clinical features, treatment, and prognosis associated with comorbid anxiety in bipolar disorder. It reveals that bipolar patients with comorbid anxiety exhibit complex clinical features, worse treatment outcomes, and a poorer prognosis. Given the significant impact of comorbid anxiety on clinical features, treatment outcomes, and prognosis, it is crucial to address this issue when treating individuals with bipolar disorder. Therefore, further research on the treatment of co-occurring anxiety in bipolar disorder patients is warranted.